Malcolm L Gefter

This inventor holds 39 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Praecis Pharmaceuticals, Inc., Immulogic Pharmaceutical Corporation, Glaxosmithkline LLC. Active years: 1998-2013.

USPTO Granted Patents = 39 (Patent Applications = 6)

% Patents Active = 84.6

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 14

Forward Citations = 843(Granted Patents)

Company Filing History:

24 out of 43

Praecis Pharmaceuticals, Inc.

patents

6 out of 36

Immulogic Pharmaceutical Corporation

Immulogic Pharmacuetical Corp.

Years Active: 1998-2013

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Sustained Drug Delivery

Amyloid Aggregation Modulators

Encoded Libraries

Peptide Binding Sequences

LHRH Antagonists

Cancer Treatment

Human T Cell Reactive Proteins

Hapten-Carrier Conjugates

FGF Receptor Activity

Drug-Abuse Therapy

D-Amino Acids

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8598089 - Methods for synthesis of encoded libraries (2013-12-03),

2. 8410028 - Methods for synthesis of encoded libraries (2013-04-02),

3. 8084419 - Pharmaceutical compositions for sustained drug delivery (2011-12-27),

4. 7989395 - Methods for identifying compounds of interest using encoded libraries (2011-08-02),

5. 7972994 - Methods for synthesis of encoded libraries (2011-07-05),

6. 7972992 - Methods for synthesis of encoded libraries (2011-07-05),

7. 7935658 - Methods for synthesis of encoded libraries (2011-05-03),

8. 7658917 - Modulators of amyloid aggregation (2010-02-09),

9. 7482008 - Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor (2009-01-27),

10. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),

11. 7037889 - Pharmaceutical compositions for sustained drug delivery (2006-05-02),

12. 6759234 - Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response (2004-07-06),

13. 6699833 - Pharmaceutical formulations for sustained drug delivery (2004-03-02),

14. 6689752 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2004-02-10),

15. 6475806 - Anchor libraries and identification of peptide binding sequences (2002-11-05),

Title: **Malcolm L Gefter: A Pioneer in Molecular Synthesis**

Introduction

Malcolm L Gefter, based in Lincoln, MA, is a prolific inventor recognized for his significant contributions to the field of molecular synthesis. With a remarkable portfolio of 39 patents, his work has greatly influenced the development of innovative methodologies in biochemistry and pharmaceuticals.

Latest Patents

Among his latest patents, it is noteworthy that he has developed methods for the synthesis of encoded libraries. This invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag. This approach enhances the ability to create diverse molecular libraries, facilitating advanced research and applications in various scientific fields.

Career Highlights

Throughout his career, Malcolm has made substantial impacts while working at prominent companies in the pharmaceutical industry, including Praecis Pharmaceuticals, Inc. and Immulogic Pharmaceutical Corporation. His tenure at these organizations has positioned him at the forefront of innovative therapeutic development and molecular research.

Collaborations

Malcolm has collaborated with notable professionals in the industry, including Gary Fred Musso and Ethan R Signer. These collaborations have not only fostered advancements in research but have also contributed to the successful execution of various innovative projects.

Conclusion

In summary, Malcolm L Gefter's dedication to innovation and excellence in the field of molecular synthesis has resulted in several groundbreaking patents. His work continues to inspire future generations of inventors and researchers aspiring to push the boundaries of science.